Sign Up to like & get
recommendations!
2
Published in 2022 at "Molecules"
DOI: 10.3390/molecules27031119
Abstract: Anemia is a major complication of chronic renal failure. To treat this anemia, prolylhydroxylase domain enzyme (PHD) inhibitors as well as erythropoiesis-stimulating agents (ESAs) have been used. Although PHD inhibitors rapidly stimulate erythropoietin (Epo) production,…
read more here.
Keywords:
epo;
phd inhibitors;
production;
epo production ... See more keywords